A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

A Phase 3 Study of Sodium Thiosulfate for Reduction of Cisplatin-Induced Ototoxicity in Children With Average-Risk Medulloblastoma and Reduced Therapy in Children With Medulloblastoma With Low-Risk Features

  • Clinical Trial Information

    Trial Contact: Dubberly, Paige D; Spinelli, Jennifer; Armatti, Julie M; Parker, Melanie; Doyle, Katherine M

  • IRB No: ACNS2031

    Protocol Abbrev: ACNS2031

    Principal Investigator: Amy A. Smith, MD

    Phase: Drug: Phase III

    Age Group: Pediatric ID: NCT05382338

  • Objective

    This phase III trial tests two hypotheses in patients with low-risk and average-risk medulloblastoma. Medulloblastoma is a type of cancer that occurs in the back of the brain.